Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
| The Manila Times
CHASKA, Minn., July 15, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ('Lifecore”) a fully integrated injectables contract development and manufacturing organization ('CDMO”), today announced that effective on July 13, 2026, Lifecore granted a restricted stock unit ('RSU”) award with respect to 3,500 shares of its common stock under Lifecore’s Equity Inducement Plan, as amended (the 'Inducement Plan”) to a newly hired employee of Lifecore.